Arcutis Biotherapeutics Presents New Positive Data from Phase 2 Studies of ARQ-151 (Topical Roflumilast Cream) in Chronic Plaque Psoriasis and Atopic Dermatitis

Suma Ramadas, PhD
Medical Affairs

Paul Theisen
Patient Acquisition

David Linetsky
Point-of-Care Marketing

Joey Cohen
Medication Adherence

Frank Burrell
Scientific Storytelling

Brenda Snow
Authentic Patient Voice

Matt Turner
Patient Affordability

Bud Bilanich
Success Coach

Daniel Sontupe
Market Access

Matthew Durham
Omnidynamic Marketing

Pat Purcell
Meeting Engagement

Amy Giles
Increasing Engagement

Stacey Gandler
Brand Nourishment

Liz Kane
Impactful Strategy